PV at ASCO 2026

PV at ASCO 2026

Panel discussion on treatment options and future research in polycythemia vera featuring Dr. Anand Patel, Dr. Aaron Gerds, Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Anthony Hunter.

PV at ASCO 2026

06/11/2026

Treatment Selection and Future Directions in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of four doctors discussing molecular responses and long-term disease control in polycythemia vera, highlighting recent research and treatment strategies.

PV at ASCO 2026

06/10/2026

Molecular Responses and Long-Term Disease Control in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of four doctors discussing treatment strategies for polycythemia vera, focusing on optimizing ropeginterferon therapy, with a city skyline background.

PV at ASCO 2026

06/09/2026

Optimizing Ropeginterferon Use in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Panel of four doctors discussing current treatment paradigms and the emerging role of Ropiginterferon in polycythemia vera (PV) at OncUpdates.

PV at ASCO 2026

06/08/2026

Current Treatment Paradigms and the Emerging Role of Ropeginterferon Alfa-2b-njft in PV

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD
Experts discuss the role of Ropoginterferon Alfa-2b in treating Polycythemia Vera, highlighting recent clinical insights and therapeutic strategies.

PV at ASCO 2026

05/31/2026

Clinical Insights: Role of Ropeginterferon Alfa-2b-njft in Polycythemia Vera

Aaron Gerds, MDAnthony M. Hunter, MDAnand Patel, MDRahul Gosain, MD, MBARohit Gosain, MD